Compare EONR & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HNR Acquisition Corp is a blank check company.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.